Results 271 to 280 of about 101,617 (297)

DPP-4 Inhibitors: Monotherapy

2013
Navjot Singh, Jubbin Jacob
openaire   +1 more source

Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4)

Best Practice and Research in Clinical Endocrinology and Metabolism, 2009
Nancy A Thornberry, Baptist Gallwitz
exaly  

DPP-4 Inhibitors: An Overview

2013
Navjot Singh, Jubbin Jacob
openaire   +1 more source

Worsening Heart Failure During the Use of DPP-4 Inhibitors

JACC: Heart Failure, 2018
Milton Packer
exaly  

Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review

Clinical Therapeutics, 2012
Vanita R Aroda, Robert R Henry, Jenny Han   +2 more
exaly  

The Unique Properties of Dipeptidyl-peptidase IV (DPP IV I CD26) and the Therapeutic Potential of DPP IV Inhibitors

Current Medicinal Chemistry, 1999
Koen Augustyns, Christine Durinx, F Goossens   +2 more
exaly  

The New insights from DPP‐4 inhibitors: their potential immune modulatory function in autoimmune diabetes

Diabetes/Metabolism Research and Reviews, 2014
Xiangbing Wang, Zhiguang Zhou
exaly  

Future perspectives for insulinotropic agents in the treatment of type 2 diabetes–DPP‐4 inhibitors and sulphonylureas

Diabetes, Obesity and Metabolism, 2010
Baptist Gallwitz, H -U Haring
exaly  

GLP-1 Receptor Agonists and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes

Hormone and Metabolic Research, 2004
Bo Ahren
exaly  

Trough DPP-4 Inhibition Differs between the Approved DPP-4 Inhibitors

MD Conference Express, 2013
openaire   +1 more source